Evogene (EVGN) Misses Q3 EPS by 1c

Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $311 thousand versus the consensus estimate of $270 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Evogene Reports Second Quarter and First Half 2026 Financial Results
• Home Depot beats estimates, reaffirms fiscal 2026 guidance
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does